Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials
Authors
Keywords
-
Journal
Frontiers in Neurology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-09-25
DOI
10.3389/fneur.2017.00486
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammatory profile discriminates clinical subtypes inLRRK2-associated Parkinson's disease
- (2017) K. Brockmann et al. EUROPEAN JOURNAL OF NEUROLOGY
- Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
- (2017) Deepti Lall et al. JOURNAL OF CLINICAL INVESTIGATION
- Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2017) Vincent Meininger et al. LANCET NEUROLOGY
- Autologous hematopoietic stem cell transplantation for MS
- (2017) Joachim Burman et al. NEUROLOGY
- Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
- (2016) Emiliano Trias et al. Journal of Neuroinflammation
- Decoding ALS: from genes to mechanism
- (2016) J. Paul Taylor et al. NATURE
- Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis
- (2016) Rosa Luisa Potenza et al. Neurotherapeutics
- C9orf72 is required for proper macrophage and microglial function in mice
- (2016) J. G. ORourke et al. SCIENCE
- Metabolic profiling distinguishes three subtypes of Alzheimer's disease
- (2015) Dale E. Bredesen Aging-US
- Granulocyte Colony-Stimulating Factor for Amyotrophic Lateral Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study of Iranian Patients
- (2015) Nasibeh Amirzagar et al. Journal of Clinical Neurology
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia
- (2015) Rowan A. Radford et al. Frontiers in Cellular Neuroscience
- Ozanezumab Dose Selection for Amyotrophic Lateral Sclerosis by Pharmacokinetic-Pharmacodynamic Modelling of Immunohistochemistry Data from Patient Muscle Biopsies
- (2015) Alienor Berges et al. PLoS One
- Interleukin-1 Antagonist Anakinra in Amyotrophic Lateral Sclerosis—A Pilot Study
- (2015) André Maier et al. PLoS One
- Neuroinflammation and M2 microglia: the good, the bad, and the inflamed
- (2014) Jonathan D Cherry et al. Journal of Neuroinflammation
- Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
- (2014) Hiroshi Mitsumoto et al. LANCET NEUROLOGY
- Insulin and IGF receptor signalling in neural-stem-cell homeostasis
- (2014) Amber N. Ziegler et al. Nature Reviews Endocrinology
- Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
- (2014) Claudio Hetz et al. NATURE REVIEWS NEUROSCIENCE
- Amyotrophic lateral sclerosis developing during adalimumab therapy for psoriatic arthritis
- (2014) A. Bougea et al. REVUE NEUROLOGIQUE
- NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study
- (2014) Robert G. Miller et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- The Interleukin-1 Family: Back to the Future
- (2013) Cecilia Garlanda et al. IMMUNITY
- Redox Regulation in Amyotrophic Lateral Sclerosis
- (2013) Sonam Parakh et al. Oxidative Medicine and Cellular Longevity
- Electrokinetically Altered Normal Saline Modulates Ion Channel Activity
- (2012) James C. Choi et al. BIOPHYSICAL JOURNAL
- Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival
- (2012) Jenny S. Henkel et al. EMBO Molecular Medicine
- Suppression of Nuclear Factor-κB Activation and Inflammation in Microglia by Physically Modified Saline
- (2012) Saurabh Khasnavis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Protection of Tregs, Suppression of Th1 and Th17 Cells, and Amelioration of Experimental Allergic Encephalomyelitis by a Physically-Modified Saline
- (2012) Susanta Mondal et al. PLoS One
- Alterations of T cell subsets in ALS: a systemic immune activation?
- (2011) M. Rentzos et al. ACTA NEUROLOGICA SCANDINAVICA
- Granulocyte colony stimulating factor attenuates inflammation in a mouse model of amyotrophic lateral sclerosis
- (2011) Eveliina Pollari et al. Journal of Neuroinflammation
- G-CSF Prevents the Progression of Structural Disintegration of White Matter Tracts in Amyotrophic Lateral Sclerosis: A Pilot Trial
- (2011) Thomas Duning et al. PLoS One
- Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature
- (2011) Melissa Padovan et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy, safety, and cost-effectiveness of glatiramer acetate in the treatment of relapsing–remitting multiple sclerosis
- (2011) Aaron Boster et al. Therapeutic Advances in Neurological Disorders
- Inflammation, demyelination, and degeneration — Recent insights from MS pathology
- (2010) Christine Stadelmann et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
- (2010) Volker Brinkmann et al. NATURE REVIEWS DRUG DISCOVERY
- Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?
- (2010) F. Barkhof et al. NEUROLOGY
- Microglial activation and chronic neurodegeneration
- (2010) Melinda E. Lull et al. Neurotherapeutics
- Mutant superoxide dismutase 1-induced IL-1 accelerates ALS pathogenesis
- (2010) F. Meissner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
- (2009) Elijah W. Stommel et al. Amyotrophic Lateral Sclerosis
- Preliminary investigation of effect of granulocyte colony stimulating factor on amyotrophic lateral sclerosis
- (2009) Yuanjin Zhang et al. Amyotrophic Lateral Sclerosis
- Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
- (2009) Vincent Meininger et al. Amyotrophic Lateral Sclerosis
- Alternative activation of macrophages: Immune function and cellular biology
- (2009) Audrey Varin et al. IMMUNOBIOLOGY
- Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy
- (2009) F. Reed Johnson et al. JOURNAL OF NEUROLOGY
- A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS
- (2008) Paul H. Gordon et al. Amyotrophic Lateral Sclerosis
- Expanding the Mind: Insulin-Like Growth Factor I and Brain Development
- (2008) A. Joseph D'Ercole et al. ENDOCRINOLOGY
- Thalidomide causes sinus bradycardia in ALS
- (2008) T. Meyer et al. JOURNAL OF NEUROLOGY
- Novel roles for Nogo receptor in inflammation and disease
- (2008) Samuel David et al. TRENDS IN NEUROSCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started